Literature DB >> 12067067

Proteolytic cleavage of molecules involved in cell death or survival pathways: a role in the control of apoptosis?

L Karran1, M J Dyer.   

Abstract

Proteolytic modification of certain key regulatory molecules involved in apoptotic and prosurvival pathways may be a feature of the control of programmed cell death. Four molecules of the Bd-2 family (BID, Bcl-2, Bax, Bcl-X(L)) have been reported to be deaved during apoptosis, as has a cellular inhibitor of apoptosis (XIAP). Two proteins involved in NF-kappaB activation, RIP and TRAF1, are cleaved during apoptosis induced by agents that activate both pathways. MEKK1, a molecule involved in a protein kinase stress signaling cascade that contributes to apoptosis and NF-kappaB activation, also undergoes cleavage. In each case, the cleavage products may result in the inactivation of a former function or the gaining of a new function, thus contributing to the delicately balanced regulation of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12067067

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  3 in total

1.  Semi-artificial Fluorescent Molecular Machine for DNA Damage Detection.

Authors:  Vladimir V Didenko; Candace L Minchew; Stewart Shuman; David S Baskin
Journal:  Nano Lett       Date:  2004-12       Impact factor: 11.189

2.  N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.

Authors:  Daming Zhu; Xuan Wu; Kenneth I Strauss; Robert H Lipsky; Zehra Qureshi; Artin Terhakopian; Antonello Novelli; Krishna Banaudha; Ann M Marini
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

3.  The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome.

Authors:  Victoria M Virador; Ben Davidson; Josephine Czechowicz; Alisha Mai; Jareer Kassis; Elise C Kohn
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.